Skip to content
DraconiticResearch
Search Sources API
197,768 studies31 sourcesUpdated 1 min ago
Peer-reviewedCC BYChild and adolescent psychiatry and mental health

Intensive group treatment for children with selective mutism: a pilot study with repeated assessments.

  1. 1Department of Clinical Child and Adolescent Psychology, Justus-Liebig-University Giessen, Otto-Behaghel-Str. 10, 35394, Giessen, Germany. [email protected].
  2. 2Department of Clinical Child and Adolescent Psychology, Justus-Liebig-University Giessen, Otto-Behaghel-Str. 10, 35394, Giessen, Germany.

Abstract

Background

Selective mutism (SM) is an anxiety disorder characterized by a persistent failure to speak in specific social situations despite speaking normally in others. Preliminary evidence suggests that intensive behavioral group interventions may be a promising treatment approach. This pilot study evaluated the outcomes of such an intervention for children with SM for the first time in a German clinical sample.Methods

Sixteen children aged five to nine with SM were included in the study and fifteen participated in an intensive group intervention based on Parent-Child-Interaction Therapy for Selective Mutism (PCIT-SM). Two baseline, one post-treatment, and one three-month follow-up assessments were conducted. Primary outcome was parent-rated SM symptom severity assessed with the Frankfurt Scale for Selective Mutism (FSSM). Remission status based on a structured clinical interview served as secondary outcome. Changes over time were analyzed using linear mixed-effects models and Cochran's Q tests.Results

SM symptom severity decreased significantly over time with large effects from baseline 1 to post-treatment (dRM = 1.03) and follow-up (dRM = 1.69). No significant differences emerged between the two baseline assessments. Remission rates increased from 0% at first baseline to 47% at follow-up. A significant overall change in diagnostic status across assessments was observed. Exploratory analyses further showed that general anxiety decreased from baseline to follow-up.Conclusions

The findings provide preliminary support for intensive group interventions based on PCIT-SM principles as a promising treatment for children with SM. Future controlled studies with larger samples and longer follow-up periods are needed to evaluate treatment mechanisms and long-term outcomes. Trial registration German Clinical Trials Register (DRKS), DRKS00040917, retrospectively registered on 13 July 2026.

Related

  1. Practice Effects on Repeated Self-Administered Digital Cognitive Assessments in Cognitively Intact Older Adults from the Framingham Heart Study: Longitudinal Observational Study.
    Kieffer Christianson, Chenglin Lyu, Cody Karjadi +10
    JMIR agingPeer-reviewedCC BYFull textPsychiatry & mental healthEurope PMC
  2. Treatment of children with Kawasaki disease complicated by selective IgA deficiency using immunoglobulin preparations: a case report.
    Kun Liang Zhang, Hui Chen
    BMC pediatricsPeer-reviewedCC BY-NC-NDFull textSurgery & anaesthesiaEurope PMCPMC
  3. Respiratory pathogen epidemiology in children under 5 years hospitalized with acute respiratory infections in Qingdao, China: a retrospective, single-center, repeated cross-sectional surveillance study
    Translational pediatricsPeer-reviewedCC BY-NC-NDFull textGeneral medicineEurope PMC
  4. Reply-Letter to the editor. Nutritional Goals in Mechanically Ventilated Children: Impact of a Standardized Enteral Protocol in a Tertiary Pediatric Intensive Care Unit
    Arthur Gaudaire, Cyril Ceci, Héléna Huguet +7
    Clinical Nutrition ESPENPeer-reviewedCC BY 4.0Full textGeneral biologyEpidemiology & public healthHAL
  5. Neurobehavioral assessments and biomarkers in school children who are highly exposed to air pollution
    Stephanie M. Holm, Nina Holland, John R. Balmes +7
    Frontiers in Public HealthPeer-reviewedCC BY 4.0Full textPharmacology & toxicologyCrossrefEurope PMCPMC
BibTeX
@article{schwenck2026intensive,
  title = {{Intensive group treatment for children with selective mutism: a pilot study with repeated assessments.}},
  author = {Christina Schwenck and Megan Williams and Jana Zimmermann-Hauel and Carolin Röse-Werkmann and Gloria Gehb and Naomi L Werkmann},
  journal = {Child and adolescent psychiatry and mental health},
  year = {2026},
  month = oct,
  doi = {10.1186/s13034-026-01203-4},
  url = {https://europepmc.org/article/MED/42972560},
  note = {CC BY},
}
RIS
TY  - JOUR
TI  - Intensive group treatment for children with selective mutism: a pilot study with repeated assessments.
AU  - Christina Schwenck
AU  - Megan Williams
AU  - Jana Zimmermann-Hauel
AU  - Carolin Röse-Werkmann
AU  - Gloria Gehb
AU  - Naomi L Werkmann
PY  - 2026
DA  - 2026/10/27
JO  - Child and adolescent psychiatry and mental health
DO  - 10.1186/s13034-026-01203-4
UR  - https://europepmc.org/article/MED/42972560
AB  - Background  Selective mutism (SM) is an anxiety disorder characterized by a persistent failure to speak in specific social situations despite speaking normally in others. Preliminary evidence suggests that intensive behavioral group interventions may be a promising treatment approach. This pilot study evaluated the outcomes of such an intervention for children with SM for the first time in a German clinical sample.Methods  Sixteen children aged five to nine with SM were included in the study and fifteen participated in an intensive group intervention based on Parent-Child-Interaction Therapy for Selective Mutism (PCIT-SM). Two baseline, one post-treatment, and one three-month follow-up assessments were conducted. Primary outcome was parent-rated SM symptom severity assessed with the Frankfurt Scale for Selective Mutism (FSSM). Remission status based on a structured clinical interview served as secondary outcome. Changes over time were analyzed using linear mixed-effects models and Cochran's Q tests.Results  SM symptom severity decreased significantly over time with large effects from baseline 1 to post-treatment (dRM = 1.03) and follow-up (dRM = 1.69). No significant differences emerged between the two baseline assessments. Remission rates increased from 0% at first baseline to 47% at follow-up. A significant overall change in diagnostic status across assessments was observed. Exploratory analyses further showed that general anxiety decreased from baseline to follow-up.Conclusions  The findings provide preliminary support for intensive group interventions based on PCIT-SM principles as a promising treatment for children with SM. Future controlled studies with larger samples and longer follow-up periods are needed to evaluate treatment mechanisms and long-term outcomes. Trial registration German Clinical Trials Register (DRKS), DRKS00040917, retrospectively registered on 13 July 2026.
SN  - 1753-2000
ER  -